Thirty-day hospital revisits after prostate brachytherapy: who is at risk?
Background: Transperineal prostate brachytherapy is a common outpatient procedure for the treatment of prostate cancer. Whereas long-term morbidity and toxicities are widely published, rates of short-term complications leading to hospital revisits have not been well described. Materials and methods:...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Prostate International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888218300096 |